| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 1418-1422, Copyright © 1996 by Endocrine Society
ARTICLES |
MA Sortino and PL Canonico
Institute of Pharmacology, University of Catania School of Medicine, Italy.
The neuroprotective action of insulin-like growth factor I (IGF-I) was tested in immortalized hypothalamic GT1-7 cells exposed to reduced glutathione depleting agents, which cause oxidative stress and cell death. The extent of cell survival was assessed by either using the 3- [4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide cytotoxicity assay or counting at the fluorescence microscope GT1-7 cells prelabeled with fluorescent dyes selective for viable and dead cells. Treatments with buthionine sulfoximine (500 microns), diethylmaleate (1 mM), and ethacrynic acid (200 microns) caused diffuse GT1-7 cell death (40-60%). Exposure of the same cells to IGF-I (either before or concomitant to the toxic agent, depending on the drug used) significantly prevented neuronal death. This effect was rapid, concentration-dependent, maximal at concentrations of 25-50 ng/ml, and mimicked by IGF-II, fibroblast growth factor, and the potent antioxidant idebenone. In contrast, IGF- I, as well as idebenone, were completely ineffective in antagonizing the toxic effect produced by different concentrations of menadione. In conclusion, the present data demonstrate a protective role for IGF-I against glutathione depleting agents-induced damage in GT1-7 cells suggesting an antioxidant action of this growth factor in hypothalamic neurons.
This article has been cited by other articles:
![]() |
V. C. Russo, P. D. Gluckman, E. L. Feldman, and G. A. Werther The Insulin-Like Growth Factor System and Its Pleiotropic Functions in Brain Endocr. Rev., December 1, 2005; 26(7): 916 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Dhandapani, M. Hadman, L. De Sevilla, M. F. Wade, V. B. Mahesh, and D. W. Brann Astrocyte Protection of Neurons: ROLE OF TRANSFORMING GROWTH FACTOR-{beta} SIGNALING VIA A c-Jun-AP-1 PROTECTIVE PATHWAY J. Biol. Chem., October 31, 2003; 278(44): 43329 - 43339. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-R. Schabitz, T. T. Hoffmann, S. Heiland, R. Kollmar, J. Bardutzky, C. Sommer, and S. Schwab Delayed Neuroprotective Effect of Insulin-Like Growth Factor-I After Experimental Transient Focal Cerebral Ischemia Monitored With MRI Stroke, May 1, 2001; 32(5): 1226 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Entingh, B. K. Law, and H. L. Moses Induction of the C/EBP Homologous Protein (CHOP) by Amino Acid Deprivation Requires Insulin-Like Growth Factor I, Phosphatidylinositol 3-Kinase, and Mammalian Target of Rapamycin Signaling Endocrinology, January 1, 2001; 142(1): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Lackey, S. L. Gray, and D. M. Henricks Does the Insulin-Like Growth Factor System Interact with Prostaglandins and Proinflammatory Cytokines During Neurodegeneration? Experimental Biology and Medicine, May 1, 2000; 224(1): 20 - 27. [Abstract] [Full Text] |
||||
![]() |
M. A. Sortino, F. Condorelli, C. Vancheri, and P. L. Canonico Tumor Necrosis Factor-{alpha} Induces Apoptosis in Immortalized Hypothalamic Neurons: Involvement of Ceramide-Generating Pathways Endocrinology, October 1, 1999; 140(10): 4841 - 4849. [Abstract] [Full Text] |
||||
![]() |
O. Dammann and A. Leviton Brain Damage in Preterm Newborns: Might Enhancement of Developmentally Regulated Endogenous Protection Open a Door for Prevention? Pediatrics, September 1, 1999; 104(3): 541 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Loddick and N. J. Rothwell Mechanisms of tumor necrosis factor alpha action on neurodegeneration: Interaction with insulin-like growth factor-1 PNAS, August 17, 1999; 96(17): 9449 - 9451. [Full Text] [PDF] |
||||
![]() |
S. Heck, F. Lezoualc'h, S. Engert, and C. Behl Insulin-like Growth Factor-1-mediated Neuroprotection against Oxidative Stress Is Associated with Activation of Nuclear Factor kappa B J. Biol. Chem., April 2, 1999; 274(14): 9828 - 9835. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Henricks, A. J. Kouba, B. R. Lackey, W. R. Boone, and S. L. Gray Identification of Insulin-Like Growth Factor I in Bovine Seminal Plasma and Its Receptor on Spermatozoa: Influence on Sperm Motility Biol Reprod, August 1, 1998; 59(2): 330 - 337. [Abstract] [Full Text] |
||||
![]() |
S. A. Loddick, X.-J. Liu, Z.-X. Lu, C. Liu, D. P. Behan, D. C. Chalmers, A. C. Foster, W. W. Vale, N. Ling, and E. B. De Souza Displacement of insulin-like growth factors from their binding proteins as a potential treatment for stroke PNAS, February 17, 1998; 95(4): 1894 - 1898. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Behl, F. Lezoualc'h, T. Trapp, M. Widmann, T. Skutella, and F. Holsboer Glucocorticoids Enhance Oxidative Stress-Induced Cell Death in Hippocampal Neurons in Vitro Endocrinology, January 1, 1997; 138(1): 101 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ostlund, H. Lindegren, C. Pettersson, and K. Bedecs Up-regulation of Functionally Impaired Insulin-like Growth Factor-1 Receptor in Scrapie-infected Neuroblastoma Cells J. Biol. Chem., September 21, 2001; 276(39): 36110 - 36115. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |